Patent Assignment
Reel/Frame 039834/0777
Assignment of Assignor's Interest
Recorded: 2016-09-22
Pages: 4
Assignors
BOSS, CHRISTOPH
Executed: 2016-04-27
BROTSCHI, CHRISTINE
Executed: 2016-04-27
GUDE, MARKUS
Executed: 2016-04-27
HEIDMANN, BIBIA
Executed: 2016-04-27
SIFFERLEN, THIERRY
Executed: 2016-04-27
VON RAUMER, MARKUS
Executed: 2016-04-27
WILLIAMS, JODI T.
Executed: 2016-04-27
Assignee
ACTELION PHARMACEUTICALS LTD.
GEWERBESTRASSE 16, ALLSCHWIL, CH-4123, SWITZERLAND
Covered Property
(1)
Crystalline Salt Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1-Yl) (5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone as Orexin Receptor Antagonist
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 13, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 042464/0407 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042464 Frame: 0407. Assignor(S) Hereby Confirms the Assignment.
Jun 28, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 043017/0022 →